Clinical Trial Update: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating umbilical cord blood stem cell transplantation for treating malignant and nonmalignant diseases in young patients. The update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia
• Langerhans Cell Histiocytosis
• Leukemia
• Lymphoma
• Myelodysplastic Syndromes
• Neuroblastoma
• Sarcoma

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Childhood Langerhans Cell Histiocytosis, Fanconi Anemia | Phase 2 | Status: UNKNOWN